← Back to NNVC

NanoViricides, Inc. Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSMar 2026Filed 15/05/2026Dec 2025Filed 15/05/2026Sep 2025Filed 15/05/2026Mar 2025Filed 15/05/2026Dec 2024Filed 15/05/2026Sep 2024Filed 15/05/2026Mar 2024Filed 15/05/2025Dec 2023Filed 15/05/2025
$0$0
−$2−$2.2−$1.8−$2.2−$2−$3.1−$1.9−$2.1
−$0.09−$0.11−$0.10−$0.14−$0.14−$0.23−$0.16−$0.18
2220171615141212

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.